FTC's Take On Drug Sales To Rivals May Cost Pharma

Law360, New York (March 12, 2013, 9:35 PM EDT) -- The Federal Trade Commission on Monday urged a New Jersey court to keep alive a case accusing Actelion Pharmaceutical Ltd. of breaching antitrust laws by refusing to supply generic rivals with samples of drugs covered by rules restricting distribution, a move that could force pharmaceutical companies to fight out expensive litigation and extend to other industries like the high-tech sector.

The FTC refused to weigh in on the merits of the claims brought by several generics companies, that argue Actelion has to provide them with samples...
To view the full article, register now.